Hyperpigmentation with daunorubicin therapy.
D003630:Daunorubicin / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010859:Pigmentation Disorders / Q000139:chemically induced*
D003630:Daunorubicin